CN113024730A - 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法 - Google Patents

一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法 Download PDF

Info

Publication number
CN113024730A
CN113024730A CN202110347214.6A CN202110347214A CN113024730A CN 113024730 A CN113024730 A CN 113024730A CN 202110347214 A CN202110347214 A CN 202110347214A CN 113024730 A CN113024730 A CN 113024730A
Authority
CN
China
Prior art keywords
hydrogel
chitosan
solution
bone
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110347214.6A
Other languages
English (en)
Other versions
CN113024730B (zh
Inventor
胡巧玲
姜质琦
董晓飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN202110347214.6A priority Critical patent/CN113024730B/zh
Publication of CN113024730A publication Critical patent/CN113024730A/zh
Application granted granted Critical
Publication of CN113024730B publication Critical patent/CN113024730B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F251/00—Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法，该水凝胶主要由改性壳聚糖、内载细胞以及促细胞生长因子组成。首先通过乳液聚合制备得到水凝胶前体溶液，主要成分为聚N‑异丙基丙烯酰胺接枝改性的壳聚糖大分子，该水凝胶能在室温下呈溶液状态，在人体生理温度环境下实现快速凝胶化。通过与细胞悬液和促细胞生长因子的混合，所得复合溶液可以在骨组织损伤部位实现原位快速凝胶化，实现细胞的原位固定，不仅可以为损伤部位提供良好的支撑，还可以促进其内部细胞的粘附、增殖、分化。由于制备简单、使用方便、响应迅速、生物相容性良好，该水凝胶可用于组织修复、药物控释、细胞培养、癌症治疗等诸多生物医学相关领域。

Description

一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用 方法
技术领域
本发明涉及一种壳聚糖基可注射水凝胶，尤其涉及一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法。
背景技术
如何高效修复由外伤、感染、肿瘤等因素引起的骨组织损伤或缺损依旧是临床医学的重要挑战。日前，自体移植和异体移植是促进骨缺陷愈合以及骨组织重塑的重要治疗手段，但两者都存在一定的弊端，例如自体移植的细胞活性不理想、迁移率较低，异体移植易引起感染或免疫排斥反应。
理想的骨组织修复再生材料不仅需要合适的力学强度在骨缺损部位提供短期支撑，还应该促进细胞黏附、增殖、分化、矿化。水凝胶材料具有高含水量、与细胞外基质相似的结构、可调控的力学性能，使其在骨修复方面有着良好的应用前景。与传统水凝胶相比，智能水凝胶因其能对外界环境变化产生响应而受到更多关注。温度敏感水凝胶是一种对外界温度变化产生响应的水凝胶，具有可注射性，温敏水凝胶中亲水基团与疏水基团的存在，可以使温敏凝胶在温度改变时发生相转变，由液态转变为固态。具有良好生物相容性的温敏可注射水凝胶可以在组织修复领域发挥极大地作用。
壳聚糖是一种天然氨基多糖，来源于生物体，是虾壳、螃蟹壳的重要组成部分。壳聚糖不仅来源广泛，还具有优异的生物相容性、抑菌性以及良好的生物可降解性。温敏壳聚糖水凝胶兼具水凝胶的特点和优良的本征属性，为骨组织修复提供了新思路和新方法。
发明内容
本发明的目的在于针对现有技术的不足，提供一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法。本发明的可注射复合壳聚糖水凝胶，主要由改性壳聚糖、内载细胞以及促细胞生长因子组成。
所述改性壳聚糖具体为聚N-异丙基丙烯酰胺接枝改性的壳聚糖。
本发明所述的一种用于骨修复的可注射复合壳聚糖水凝胶，其前体的制备方法是：
1)聚N-异丙基丙烯酰胺接枝改性的壳聚糖生物大分子的制备：按照质量计，将1-15份壳聚糖、0.1-5份酸、0.01-10份引发剂、1-20份N-异丙基丙烯酰胺、50-100份溶剂加入烧杯中，搅拌溶解均匀后，加热至40-60℃反应1-12小时，随后将溶液转移入透析袋中，用去离子水反复透析，冷冻干燥得到聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末；
2)聚N-异丙基丙烯酰胺接枝改性的壳聚糖水溶液的制备：将1-20份1)中的聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末加入80-99份PBS溶液中，低温环境下搅拌溶解均匀后得到水凝胶前体溶液；
上述技术方案中，进一步的，
所述壳聚糖的分子量为3万-200万，脱乙酰度为65％-99％。
所述酸为盐酸、醋酸、磷酸、柠檬酸、酒石酸、丙烯酸中的一种或几种。
所述引发剂为偶氮二异丁腈、偶氮二异庚腈、偶氮二异丁酸二甲酯、过氧化氢、过硫酸铵、过硫酸钾、叔丁基过氧化氢中的一种或几种。
所述溶剂为去离子水、乙醇、DMSO中的一种或几种。
所述低温环境下为4℃-25℃。
本发明所述的一种用于骨修复的可注射复合壳聚糖水凝胶溶液的使用方法，具体包括如下步骤：
(1)可注射复合壳聚糖水凝胶溶液的制备：将所述步骤2)中的水凝胶前体溶液进行灭菌，将10-50份灭菌后的水凝胶前体溶液、5份内载细胞的细胞悬液与0.1-5份促细胞生长因子低温环境下进行共混，混合均匀得到可注射复合壳聚糖水凝胶溶液。
(2)使用注射器或移液枪缓慢吸取一定量步骤1)中的可注射壳聚糖水凝胶溶液，将其缓慢注射到受损的骨组织创伤部位，使溶液填满缺损部位，静待溶液凝胶化即可。
上述技术方案中，进一步的，
所述内载细胞为胚胎干细胞、间充质干细胞、脂肪干细胞、成骨细胞、软骨细胞中的一种或几种。
所述细胞悬液中内载细胞的浓度为2万-200万/ml，细胞培养基为完全培养基、干细胞生长培养基或成骨分化培养基。
所述低温环境为4℃-25℃。
所述受损的骨组织为硬骨或软骨等，其中所述硬骨为长骨或扁骨，如股骨、胫骨、颅骨等；所述软骨为关节软骨等。
用于硬骨组织损伤修复时所述促细胞生长因子为羟基磷灰石HAP、胶原、骨形成蛋白BMP、RGD分子以及其他氨基酸或多肽中的一种或几种；用于软骨组织损伤修复时所述促细胞生长因子为脱钙骨基质DBM、2-([1,1-联苯]-4-基氨基甲酰)苯甲酸KGN、胶原蛋白、鹿茸多肽PAP、胰岛素样生长因子IGF、转化生长因子TGF、基质细胞衍生因子SDF、骨形成蛋白BMP、RGD分子以及其他氨基酸或多肽中的一种或几种。
本发明的有益效果在于：
本发明首先通过乳液聚合制备得到水凝胶前体溶液，主要成分为聚N-异丙基丙烯酰胺接枝改性的壳聚糖大分子，该水凝胶具有温度敏感特性，能在室温环境下呈溶液状态，在人体生理温度环境下实现快速凝胶化。该温敏水凝胶具有优异的生物相容性，通过与细胞悬液和促细胞生长因子的混合，该水凝胶溶液可以在骨组织损伤部位实现原位快速凝胶化，实现细胞的原位固定，不仅可以为损伤部位提供良好的支撑，还可以促进其内部细胞的粘附、增殖、分化。由于制备简单、使用方便、响应迅速、生物相容性良好等诸多特点，该水凝胶可用于组织修复、药物控释、细胞培养、癌症治疗等诸多生物医学相关领域，特别是应用于骨组织修复再生。
具体实施方式
以下结合具体实例进一步说明本发明。
实施例1：
1)称取1.5g粘均分子量为100W、脱乙酰度为90％的壳聚糖粉末、1.75gN-异丙基丙烯酰胺、0.175g过硫酸铵，分散在95mL去离子水中，然后，加入0.5mL的盐酸，搅拌溶解均匀后，加热至60℃反应8小时，随后将溶液转移入透析袋中，用去离子水反复透析，冷冻干燥得到聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末；
2)将1-20份步骤1)中的聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末加入80-99份PBS溶液中，10℃环境下搅拌溶解均匀后得到水凝胶前体溶液；
3)将步骤2)中的水凝胶前体溶液进行灭菌，将30份2)中的水凝胶前体溶液、5份骨髓间充质干细胞细胞悬液与0.1份HAP于10℃下进行共混，混合均匀得到可注射复合壳聚糖水凝胶溶液；
4)使用注射器或移液枪缓慢吸取一定量步骤3)的可注射复合壳聚糖水凝胶溶液，将其缓慢注射到受损的骨组织缺陷部位，使溶液填满缺损部位，静待一定时间后，溶液即可完全凝胶化。
实施例2：
1)称取1.5g粘均分子量为100W、脱乙酰度为90％的壳聚糖粉末、1.75gN-异丙基丙烯酰胺、0.175g过硫酸铵，分散在95mL去离子水中，然后，加入0.5mL的盐酸，搅拌溶解均匀后，加热至60℃反应8小时，随后将溶液转移入透析袋中，用去离子水反复透析，冷冻干燥得到聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末；
2)将1-20份步骤1)中的聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末加入80-99份PBS溶液中，10℃环境下搅拌溶解均匀后得到水凝胶前体溶液；
3)将步骤2)中的水凝胶前体溶液进行灭菌，将20份2)中的水凝胶前体溶液、5份骨髓间充质干细胞细胞悬液与0.2份多肽分子与10℃环境下进行共混，混合均匀得到可注射复合壳聚糖水凝胶溶液；
4)使用注射器或移液枪缓慢吸取一定量步骤3)的可注射复合壳聚糖水凝胶溶液，将其缓慢注射到受损的骨组织缺陷部位，使溶液填满缺损部位，静待一定时间后，溶液即可完全凝胶化。
实施例3：
1)称取1.5g粘均分子量为100W、脱乙酰度为90％的壳聚糖粉末、1.75gN-异丙基丙烯酰胺、0.175g过硫酸铵，分散在95mL去离子水中，然后，加入0.5mL的盐酸，搅拌溶解均匀后，加热至60℃反应8小时，随后将溶液转移入透析袋中，用去离子水反复透析，冷冻干燥得到聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末；
2)将1-20份步骤1)中的聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末加入80-99份PBS溶液中，10℃环境下搅拌溶解均匀后得到水凝胶前体溶液；
3)将步骤2)中的水凝胶前体溶液进行灭菌，将50份2)中的水凝胶前体溶液、5份成骨细胞细胞悬液与1份HAP于10℃环境下进行共混，混合均匀得到可注射复合壳聚糖水凝胶溶液；
4)使用注射器或移液枪缓慢吸取一定量步骤3)的可注射复合壳聚糖水凝胶溶液，将其缓慢注射到受损的骨组织缺陷部位，使溶液填满缺损部位，静待一定时间后，溶液即可完全凝胶化。

Claims (10)

1.一种用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，该水凝胶主要由改性壳聚糖、内载细胞以及促细胞生长因子组成，所述改性壳聚糖为聚N-异丙基丙烯酰胺接枝改性的壳聚糖，所述水凝胶的前体的制备方法具体包括如下步骤：
1)聚N-异丙基丙烯酰胺接枝改性的壳聚糖生物大分子的制备：按照质量计，将1-15份壳聚糖、0.1-5份酸、0.01-10份引发剂、1-20份N-异丙基丙烯酰胺、50-100份溶剂加入烧杯中，搅拌溶解均匀后，加热至40-80℃反应1-12小时，随后将溶液转移入透析袋中，用去离子水反复透析，冷冻干燥得到聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末；
2)聚N-异丙基丙烯酰胺接枝改性的壳聚糖水溶液的制备：将1-20份1)中的聚N-异丙基丙烯酰胺接枝改性的壳聚糖粉末加入80-99份PBS溶液中，低温环境下搅拌溶解均匀后得到水凝胶前体溶液。
2.根据权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，步骤1)中所述壳聚糖的分子量为3万-200万，脱乙酰度为65％-99％。
3.根据权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，步骤1)中所述酸为盐酸、醋酸、磷酸、柠檬酸、酒石酸、丙烯酸中的一种或几种。
4.根据权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，步骤1)中所述引发剂为偶氮二异丁腈、偶氮二异庚腈、偶氮二异丁酸二甲酯、过氧化氢、过硫酸铵、过硫酸钾、叔丁基过氧化氢中的一种或几种。
5.根据权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，步骤1)中所述溶剂为去离子水、乙醇、DMSO中的一种或几种。
6.根据权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶，其特征在于，步骤2)中所述低温环境为4℃-25℃。
7.一种如权利要求1所述的用于骨修复的可注射复合壳聚糖水凝胶的使用方法，其特征在于，具体包括如下步骤：
(1)可注射复合壳聚糖水凝胶溶液的制备：将权利要求1所述步骤2)中的水凝胶前体溶液进行灭菌，将10-50份灭菌后的水凝胶前体溶液、5份内载细胞的细胞悬液与0.1-5份促细胞生长因子4℃-25℃下进行共混，混合均匀得到可注射复合壳聚糖水凝胶溶液；
(2)使用注射器或移液枪吸取步骤(1)中的可注射壳聚糖水凝胶溶液，将其注射到受损的骨组织创伤部位，使溶液填满缺损部位，静待溶液凝胶化即可。
8.根据权利要求7所述的一种用于骨修复的可注射复合壳聚糖水凝胶的使用方法，其特征在于，步骤(1)中所述内载细胞为胚胎干细胞、间充质干细胞、脂肪干细胞、成骨细胞、软骨细胞中的一种或几种。
9.根据权利要求7所述的一种用于骨修复的可注射复合壳聚糖水凝胶的使用方法，其特征在于，所述细胞悬液中内载细胞的浓度为2万-200万/ml，细胞培养基为完全培养基、干细胞生长培养基或成骨分化培养基。
10.根据权利要求7所述的一种用于骨修复的可注射复合壳聚糖水凝胶的使用方法，其特征在于，所述受损的骨组织为硬骨或软骨，其中所述硬骨为长骨或扁骨，；所述软骨为关节软骨；用于硬骨组织损伤修复时步骤(1)中所述促细胞生长因子为羟基磷灰石HAP、胶原、骨形成蛋白BMP、RGD分子中的一种或几种；用于软骨组织损伤修复时所述促细胞生长因子为脱钙骨基质DBM、2-([1,1-联苯]-4-基氨基甲酰)苯甲酸KGN、胶原蛋白、鹿茸多肽PAP、胰岛素样生长因子IGF、转化生长因子TGF、基质细胞衍生因子SDF、骨形成蛋白BMP、RGD分子中的一种或几种。
CN202110347214.6A 2021-03-31 2021-03-31 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法 Active CN113024730B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110347214.6A CN113024730B (zh) 2021-03-31 2021-03-31 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110347214.6A CN113024730B (zh) 2021-03-31 2021-03-31 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法

Publications (2)

Publication Number Publication Date
CN113024730A true CN113024730A (zh) 2021-06-25
CN113024730B CN113024730B (zh) 2022-05-31

Family

ID=76452967

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110347214.6A Active CN113024730B (zh) 2021-03-31 2021-03-31 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法

Country Status (1)

Country Link
CN (1) CN113024730B (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113633826A (zh) * 2021-06-30 2021-11-12 重庆医科大学附属第三医院(捷尔医院） 一种含有高活性促骨生长因子的骨修复生物材料及用途
CN114432498A (zh) * 2021-09-08 2022-05-06 北京大学口腔医学院 一种骨修复材料及其制备方法和应用
CN115702952A (zh) * 2021-08-10 2023-02-17 上海交通大学医学院附属第九人民医院 基于可注射型水凝胶支架材料构建的可注射骨及其应用
CN116371381A (zh) * 2023-04-28 2023-07-04 浙江大学 一种污染物响应型纳米零价铁复合功能材料及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100120149A1 (en) * 2008-11-07 2010-05-13 Korea Institute Of Science And Technology Cell aggregate-hydrogel-polymer scaffold complex for cartilage regeneration, method for the preparation thereof and composition comprising the same
CN108727833A (zh) * 2017-12-07 2018-11-02 西南交通大学 一种用于骨/软骨修复的粘附超强抗菌水凝胶的制备方法
CN108744057A (zh) * 2018-06-19 2018-11-06 西南交通大学 一种可注射复合凝胶及其制备方法和应用
CN109851716A (zh) * 2019-01-30 2019-06-07 浙江大学 一种具有温度敏感特性的水溶性壳聚糖及其制备方法
CN111068116A (zh) * 2019-12-28 2020-04-28 河北柯瑞生物医药有限公司 一种注射用软骨修复温敏凝胶及其制备方法
CN112250798A (zh) * 2020-09-18 2021-01-22 生物岛实验室 水凝胶和间充质干细胞的制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100120149A1 (en) * 2008-11-07 2010-05-13 Korea Institute Of Science And Technology Cell aggregate-hydrogel-polymer scaffold complex for cartilage regeneration, method for the preparation thereof and composition comprising the same
CN108727833A (zh) * 2017-12-07 2018-11-02 西南交通大学 一种用于骨/软骨修复的粘附超强抗菌水凝胶的制备方法
CN108744057A (zh) * 2018-06-19 2018-11-06 西南交通大学 一种可注射复合凝胶及其制备方法和应用
CN109851716A (zh) * 2019-01-30 2019-06-07 浙江大学 一种具有温度敏感特性的水溶性壳聚糖及其制备方法
CN111068116A (zh) * 2019-12-28 2020-04-28 河北柯瑞生物医药有限公司 一种注射用软骨修复温敏凝胶及其制备方法
CN112250798A (zh) * 2020-09-18 2021-01-22 生物岛实验室 水凝胶和间充质干细胞的制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PENTLAVALLI, S等: "Simple Radical Polymerization of Poly(Alginate-Graft-N-Isopropylacrylamide) Injectable Thermoresponsive Hydrogel with the Potential for Localized and Sustained Delivery of Stem Cells and Bioactive Molecul", 《MACROMOLECULAR BIOSCIENCE》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113633826A (zh) * 2021-06-30 2021-11-12 重庆医科大学附属第三医院(捷尔医院） 一种含有高活性促骨生长因子的骨修复生物材料及用途
CN115702952A (zh) * 2021-08-10 2023-02-17 上海交通大学医学院附属第九人民医院 基于可注射型水凝胶支架材料构建的可注射骨及其应用
CN114432498A (zh) * 2021-09-08 2022-05-06 北京大学口腔医学院 一种骨修复材料及其制备方法和应用
CN116371381A (zh) * 2023-04-28 2023-07-04 浙江大学 一种污染物响应型纳米零价铁复合功能材料及其应用

Also Published As

Publication number Publication date
CN113024730B (zh) 2022-05-31

Similar Documents

Publication Publication Date Title
CN113024730B (zh) 一种用于骨修复的可注射复合壳聚糖水凝胶的制备及使用方法
Bai et al. Bioactive hydrogels for bone regeneration
Venkatesan et al. Alginate composites for bone tissue engineering: A review
Wang et al. The functional response of alginate-gelatin-nanocrystalline cellulose injectable hydrogels toward delivery of cells and bioactive molecules
Wahid et al. Nanocomposite scaffolds for tissue engineering; properties, preparation and applications
Pighinelli et al. Chitosan–hydroxyapatite composites
Zhao et al. Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold
CN110665061A (zh) 一种脱细胞支架溶液-GelMA水凝胶复合材料及制备方法
CN111068116B (zh) 一种注射用软骨修复温敏凝胶及其制备方法
CN112972760B (zh) 一种负载内皮细胞外基质的3d打印骨缺损修复支架及其制备方法
CN113069412A (zh) 一种用于皮肤创伤修复的可注射复合壳聚糖水凝胶的制备方法
WO2022116359A1 (zh) 一种负载骨形成蛋白的水凝胶、制备方法及应用
CN113384753A (zh) 一种含脂肪间充质干细胞的可注射温敏复合型水凝胶及其制备方法和应用
Chhibber et al. Hydrogels in tissue engineering
CN110218342A (zh) 琼脂糖-明胶接枝物温敏水凝胶及其制备方法与应用
CN104587525A (zh) 包含血小板及透明质酸的支架及其制备方法
CN103819694A (zh) 一种具有细胞相容性的丝素蛋白水凝胶及其制备方法
EP3151874A1 (en) Collagen biomaterials
CN104307040A (zh) 一种组织工程用具控释能力的注射式水凝胶及其应用
CN102327643B (zh) 一种用于骨组织再生的生物支架
Lapomarda et al. Pectin-based scaffolds for tissue engineering applications
CN115282339B (zh) 一种交联透明质酸/羟基磷灰石可注射材料、制备方法及应用
CN114887116B (zh) 一种负载间充质干细胞外基质的3d打印骨缺损修复支架及其制备方法
CN106860912B (zh) 一种体内原位载药水凝胶载体及其制备方法和应用
CN110251726A (zh) 一种复合人工骨材料及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant